Influence of Maternal Diabetes on Placental Fibroblast Growth Factor-2 Expression,Proliferation,and Apoptosis

Abstract

Objective: Type I diabetes mellitus during pregnancy is associated with dysregulation of the oxygen and glucose metabolic pathways, both of which affect placental villous growth and function. Alteration of placental development in women with diabetes may contribute to the increased risk of preeclampsia, macrosomia, or fetal growth restriction.

Methods: To evaluate placental growth in the setting of maternal diabetes, immunohistochemical techniques were used to examine fibroblast growth factor-2 (FGF-2) expression, cell proliferations (Ki67), and apoptosis (Apo-Tag) in placentas from diabetic and nondiabetic patients.

Results: Immunostaining for FGF-2 in placentas from diabetic women demonstrated an increase in intensity within the villous stroma and syncytiotrophoblast (P < .05). Associated with these changes in FGF-2 expression, placentas from diabetic women showed no change in villous mitotic activity but did show decreased stromal compartment apoptosis. When expressed as a ratio of Ki67-positive: Apo-Tag-positive nuclei as an index of relative cell turnover, the stromal compartment showed a significant trend towards decreased nucleic turnover (P < .05), suggesting relative tissue growth in diabetic patients.

Conclusion: Increased FGF-2 expression and decreased stromal cell compartment turnover in the diabetic placenta might be a compensatory mechanism in response to the altered physiologic milieu of maternal diabetes on placental function.

Keywords

Apoptosis FGF-2 hyperglycemia placenta proliferation

Get full access to this article

View all access options for this article.

References

1. Sanin LH , Lopez SR , Olivares ET , Terrazas MC , Silva MA , Carrillo ML . Relation between birth weight and placenta weight. Biol Neonate 2001;80:113-117.

2. Hill DJ , Tevaarwerk GJM , Caddell C , Arany E , Kilkenny D , Gregory M . Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: Relationship to fetal and placental size. J Clin Endocrinol Metab 1995;80:2626-2632.

3. Hildebrandt VA , Babischkin JS , Koos RD , Pepe GJ , Albrecht ED . Developmental regulation of vascular endothelial growth/permeability factor messenger ribonucleic acid levels in and vascularization of the villous placents during baboon pregnancy. Endocrinology 2001;143:2050-2057.

4. Ahmed A , Dunk C , Ahmed S , Khaliq A . Regulation of placental vascular endothelial growth factor (VEGF) and placental growth factor (PIGF) and soluble Flt-1 by oxygen—a review. Placenta 2000;21(Suppl A):S16-S24.

5. Ong K , Kratzsch J , Keiss W , Costello M , Scott C , Dunger D . Size at birth and cord blood levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. Avon Longitudinal Study of Pregnancy and Childhood. The ALSPAC Study Team. J Clin Endocrinol Metab 2000;85:4266-4269.

6. Shams M , Ahmed A . Localization of mRNA for basic fibroblast growth factor in human placenta. Growth Factors 1994;11:105-111.

7. Chen Y , Zhao X . Shaping limbs by apoptosis. J Exp Zool 1998;282:691-702.

8. Vaskivuo TE , Stenback F , Karhumaa P , Risteli J , Dunkel L , Tapanainen JS . Apoptosis and apotosis-related proteins in human endometrium. Mol Cell Endocrinol 2000;165:75-83.

9. Ferriani RA , Ahmed A , Sharkey A , Smith SK . Colocalization of acidic and basic fibroblast growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. Growth Factors 1994;10:259-268.

10.

10. Lepercq J , Taupin P , Dubois-Laforgue D , et al. Heterogeneity of fetal growth in type I diabetic pregnancy. Diabetes Metab 2001;27:339-344.

11.

11. Leushner JRA , Tevaarwerk GJM , Clarson CL , Harding PGR , Chance GW , Haust MD . Analysis of collagens of diabetic placental villi. Cell Mol Biol 1986;32:27-35.

12.

12. arany E , Hill DJ . Fibroblast growth factor-2 and fibroblast growth factor receptor-1 mRNA expression and peptide localization in placentae from normal and diabetic pregnancies. Placenta 1998;19:133-142.

13.

13. Désiré L , Courois Y , Jeanny JC . Endogenous and exogenous fibroblast growth factor 2 supports survival of chick retinal neurons by control of neuronal bcl-xL and bcl-2 expression through a fibroblast growth factor receptor 1- and ERK-dependent pathway. J Neurochem 2000;75:151-163.

14.

14. Zhao Z , Rivkees SA . Programmed cell death in the developing heart: Regulation by BMP4 and FGF2. Dev Dynamics 2000;217:388-400.

15.

15. Lee SH , Schloss DJ , Swain JL . Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor. J Biol Chem 2000;275:33679-33687.

16.

16. Lynch K , Fernandez G , Pappalardo A , Peluso JJ . Basic fibroblast growth factor inhibits apoptosis of spontaneously immortalized granulosa cells by regulating intracellular free calcium levels through a protein kinase Cδ-dependent pathway. Endocrinology 2000;141:4209-4217.

17.

17. Phelan SA , Ito M , Locken MR . Neural tube defects in embryos of diabetic mice: Role of Pax-3 gene and apoptosis. Diabetes 1997;46:1189-1197.

18.

18. Moley KH , Chi MM , Knudson CM , Korsmeyer SJ , Mueckler MM . Hyperglycemia induces apoptosis in preimplantation embryos via cell death effector pathways. Nat Med 1998;12:1421-1424.

19.

19. Benirschke K , Kaufmann P . Pathology of the human placenta. 4th ed. Berlin, Germany: Springer-Verlag, 2000.

20.

20. Sibai BM . Risk factors, pregnancy complication, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern Fetal Med 2000;9:62-65.

21.

21. Desposito F , Cunniff C , Frias JL , Panny SR , Trotter TL , Wappner RS . Folic acid for the prevention of neural tube defects. Am Acad Pediatr 1999;104:325-327.

22.

22. Moley KH . Hyperglycemia and apoptosis: Mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab 2001;12:78-82.

23.

23. karsan A , Yee E , Poirier GG , Zhou P , Craig R , Harlan JM . Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 1997;151:1775-1784.

24.

24. Sakuragi N , Matsuo H , Coukos G , et al. Differentiation-dependent expression of the bcl-2 protooncogene in the human trophoblast lineage. J Soc Gynecol Investig 1994;1:164-172.

25.

25. Chan CCW , Lao TT , Cheung ANY . Apototic and proliferative activities in first trimester placentae. Placenta 1999;20:223-227.

26.

26. Qiao S , Nagasaka T , Harada T , Nakashima N . p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. Placenta 1998;19:361-369.

27.

27. Marana HRC , Andrade JM , Martins GA , Silva JS , Sala MA , Cunha SP . A morphometric study of maternal smoking on apoptosis in the syncytiotrophoblast. Int J Gynecol Obstet 1998;61:21-27.

28.

28. Weiss U , Cervar M , Puerstner P , et al. Hyperglycaemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast. Diabetologia 2001;44:209-219.